Day # 27: Medical Workup for Depression
- Marcus Hunt
- Aug 18, 2020
- 4 min read
Updated: Jan 2, 2024
Welcome back to our current theme of depressive disorders. Today we will round out some additional clinical pearls to include what medical work-up could be pursued in a patient with new depressive symptoms.
Today's Content Level: Intermediate
Introduction
•If you remember back to the psychotic disorders theme you may remember that we stressed the importance of medical workup for psychosis before attributing it to a psychiatric diagnosis. We discussed the importance of determining if these symptoms are caused primarily by a medical or neurological condition or induced by medications or other substances.
•Medical workup for depressive disorders is often less revealing as compared to psychotic disorders, and the assessment and diagnosis of depressive disorders are based on clinical interviews and examinations. However, focused tests are indicated in some circumstances and warranted to rule out other medical conditions that can cause or contribute to depressive disorders.
•In previous lessons (day 22, 24, and 25) we discussed the clinical features and symptoms of depression and how to evaluate this in a clinical interview. Today's discussion will focus on the medical workup in specific patient populations.
•Clinical interview -> should address all current and significant past general medical illness, medications, substance use, review of systems, and family medical and psychiatric history in order to identify potential medical contributors of the depressive condition.
•Review the vital signs. If they are normal they don't tell you much, but if abnormal this can be the first clue that something other than purely psychiatric is going on.
•Physical exam -> in most cases a general physical examination is not likely to reveal an underlying cause of depression. It is still recommended for new onset depression, severe depression, treatment resistant depression, and in those who have or are at risk for chronic medical conditions. A more detailed physical exam should be pursued if indicated based on the patient's history and review of systems.
Labs and Imaging
•The utility of screening laboratory tests for patients with depression has not been consistently demonstrated. Similar to the physical exam comments above it is still often recommended in certain scenarios.
Labs are commonly performed in the following scenarios: new onset depression, severe depression, treatment-resistant depression, and in patients who have or are at risk for chronic medical conditions. 1
•It can be particularly important if the patient has no known psychosocial content or precipitant for the new depressive episode or if severely depressed patients have melancholic or psychotic features.
Possible laboratory tests include:
•CBC (complete blood count): screen for underlying anemia and infection which can contribute to low mood and energy.
•CMP (complete metabolic): rule out electrolyte disturbances, glucose, renal failure (creatinine and BUN), and liver function panel (alcohol, fatty liver, hepatitis).
•UA (Urinalysis) and Urine toxicology: screen for alcoholism and drugs of abuse.
•TSH (thyroid stimulating hormone): hypothyroidism can classically present as depressed mood, decreased energy, appetite change, and weight gain.
•Beta hCG (pregnancy test): affects treatment decisions! This will be discussed in later lessons in detail.
•FTA-ABS (fluorescent treponemal antibody absorption) or RPR (rapid plasma reagin): testing for syphilis. If not treated, 30% of patients may develop tertiary syphilis, where neurosyphilis is included. Neurosyphilis can present a variety of psychiatry symptoms, including mania, depression, psychosis and dementia.
•HIV: the classical gold standard used to be ELISA and confirmed with western blot (beyond the scope of this article). Now commonly diagnosed with an HIV viral load. Three technologies measure HIV viral load in the blood: reverse transcription polymerase chain reaction (RT-PCR), branched DNA (bDNA) and nucleic acid sequence-based amplification assay (NASBA). Can present as a variety of psychiatric symptoms.
•Other diagnostic tests that are less commonly included in standard order sets, but should still be considered in certain patients. These additional tests should be pursued as guided by the medical history, review of symptoms, and physical examination. Consider the following:
•Vitamin B12/Folate: Both low folate and low vitamin B12 status have been found in studies of depressed patients, and an association between depression and low levels of the two vitamins is found in studies of the general population. 2
•Vitamin D: Low vitamin D levels have also been associated with depression as well as other psychiatric conditions and some studies suggest modest improvements in mood after supplementation in combination with other standard of care treatments. Also, patients with low vitamin D levels may not respond to treatments until corrected. 3
•Iron: Low iron levels, even if not anemic, is correlated to depressed mood. 4
•Endocrine and Autoimmune: In addition to thyroid abnormalities discussed above there are other less common endocrine disorders that can lead to depression and other psychiatric symptoms. Only screen for these if other warnings signs in the patient. Examples include but not limited to adrenal insufficiency, lupus, sjogrens, celiac disease, multiple sclerosis, etc...
•Brain CT or MRI (computed tomography or magnetic resonance imaging): these studies are typically reserved for patients who's presentation and history suggests an increased likelihood of structural brain disease such as those with focal neurologic signs on physical exam or persistent cognitive impairment. It also may be reasonable to obtain in geriatric patients with new onset depression. 5
Conclusion
Good work today. I hope this was a helpful discussion on some of the testing available for the potential medical causes of depression. We are now at the point that we can start discussing the treatment options for depressive disorders. In the coming days we will discuss nonpharm options (TMS, ECT, light therapy, etc.), psychotherapy, and pharmacotherapy. See you then!
Resources today include:
The articles linked in the body of the article
UpToDate article
See our full list of book recommendations
If you enjoy this content and would like to support the website then consider donating
Bullet Psych is an Amazon Associate and we receive a small commission if you use our links for the purchase of our recommended resources



The nuanced challenges of maintaining mental health as we age are often underestimated, yet they profoundly impact overall quality of life. This is particularly true when considering how subtle shifts in mood or energy can be dismissed as 'just part of getting older,' when they might signal something more significant. One of the biggest hurdles in addressing these issues effectively is often the initial identification and assessment of symptoms. For those looking for a structured approach to this, exploring a reliable geriatric depression screening tool can be incredibly beneficial.
"I appreciate your emphasis on the diagnostic role of clinical interviews for depressive disorders, even as medical workup helps rule out confounding conditions. This distinction from psychotic disorders is key. This makes the quality and structure of those interviews paramount. Ensuring a consistent approach to symptom evaluation is vital for accurate assessment. Given the subjectivity of depressive symptoms, having reliable, standardized tools can significantly enhance the initial assessment and ongoing monitoring process. For those looking to integrate such structured screening, you might find understanding and utilizing the PHQ-9 questionnaire a valuable next step in quantifying and tracking symptom severity."
"Marcus, I really appreciate your nuanced point that while medical workup for depressive disorders is often less revealing than for psychotic disorders, the assessment heavily relies on clinical interviews and examinations. This distinction is vital for clinicians to understand, preventing unnecessary tests while focusing on the core diagnostic process. Building on that, standardizing elements of these clinical interviews can be incredibly helpful for consistent evaluation and tracking patient progress. For those looking to integrate a structured, evidence-based approach, exploring resources like the PHQ-9 for depression assessment and monitoring can provide a valuable framework."